BlackRock Japan’s Ligand Pharmaceuticals LGND Stock Holding History

BlackRock Japan’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$19K	Sell	297 -3	-1%	-$189	﹤0.01%	1131
2016 Q3	$19K	Sell	300 -925	-76%	-$67.9K	﹤0.01%	1123
2016 Q2	$91K	Buy	1,225 +4	+0.3%	+$297	﹤0.01%	909
2016 Q1	$82K	Hold	1,221	–	–	﹤0.01%	947
2015 Q4	$83K	Sell	1,221 -71	-5%	-$4.38K	﹤0.01%	940
2015 Q3	$69K	Sell	1,292 -14,262	-92%	-$865K	﹤0.01%	912
2015 Q2	$979K	Buy	15,554 +13,972	+883%	+$762K	﹤0.01%	743
2015 Q1	$76K	Sell	1,582 -2,438	-61%	-$93.4K	﹤0.01%	990
2014 Q4	$133K	Buy	4,020 +1,412	+54%	+$45.9K	﹤0.01%	927
2014 Q3	$76K	Sell	2,608 -292	-10%	-$9.69K	﹤0.01%	993
2014 Q2	$113K	Sell	2,900 -160	-5%	-$6.49K	﹤0.01%	921
2014 Q1	$128K	Buy	3,060 +1,162	+61%	+$48.4K	﹤0.01%	1020
2013 Q4	$62K	Sell	1,898 -2,111	-53%	-$68.8K	﹤0.01%	1096
2013 Q3	$108K	Sell	4,009 -2,799	-41%	-$78.7K	﹤0.01%	996
2013 Q2	$159K	Buy	+6,808	New	+$122K	﹤0.01%	905

Other funds holding LGND

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock Japan's LGND Position: Q4 2016 in Review

BlackRock Japan reduced its Ligand Pharmaceuticals (LGND) stake by 1% in Q4 2016, selling an estimated $189 and leaving 297 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #1131.

BlackRock Japan first reported a position in LGND in Q2 2013 and has held it in 15 quarters since. The position peaked at $979K in Q2 2015. 270 funds tracked by Wall St. Rank hold LGND as of Q4 2016.

BlackRock Japan held 297 shares of Ligand Pharmaceuticals worth $19K as of Q4 2016.
BlackRock Japan sold 3 Ligand Pharmaceuticals shares in Q4 2016, an estimated $189.
Ligand Pharmaceuticals made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1131 holding.
BlackRock Japan first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
BlackRock Japan's Ligand Pharmaceuticals position peaked at $979K in Q2 2015.
270 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.